• 1. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Serotonins
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Tryptamines and derivatives Serotonins

N-Boc-5-hydroxytryptophan Methyl Ester (CAS No. 203736-17-8): A Comprehensive Overview in Modern Chemical Biology and Medicine

N-Boc-5-hydroxytryptophan Methyl Ester, with the chemical identifier CAS No. 203736-17-8, represents a significant compound in the realm of chemical biology and pharmaceutical research. This compound, derived from the essential amino acid tryptophan, has garnered considerable attention due to its structural and functional versatility. The presence of both a Boc (tert-butoxycarbonyl) protecting group and a methyl ester at the 5-hydroxy position endows it with unique reactivity, making it a valuable intermediate in synthetic chemistry and a promising candidate for various therapeutic applications.

The< strong>Boc group on the nitrogen atom of the amino acid moiety serves as an effective protecting group, preventing unwanted reactions such as deprotonation or nucleophilic attack. This protection is crucial in multi-step synthetic pathways, ensuring that the reactive sites of the molecule remain intact until the desired modifications are achieved. Meanwhile, the< strong>methyl ester at the 5-hydroxy position introduces additional functionality that can be selectively modified or hydrolyzed to yield different derivatives. Such modifications are pivotal in drug design, allowing researchers to fine-tune the pharmacokinetic and pharmacodynamic properties of potential therapeutics.

In recent years, there has been growing interest in exploring the therapeutic potential of tryptophan derivatives, particularly those targeting serotoninergic pathways. Serotonin, also known as 5-hydroxytryptamine (5-HT), plays a critical role in regulating mood, sleep, appetite, and pain perception. Compounds that modulate serotonin levels or receptor activity have broad implications in treating neurological and psychiatric disorders. N-Boc-5-hydroxytryptophan Methyl Ester is being investigated for its potential to serve as a precursor in synthesizing novel serotonin receptor agonists and antagonists.

One of the most exciting areas of research involving N-Boc-5-hydroxytryptophan Methyl Ester is its application in developing treatments for depression and anxiety disorders. Preclinical studies have demonstrated that certain derivatives of tryptophan can enhance serotonin synthesis or modulate serotonin receptor activity, leading to improved symptoms in animal models of these conditions. The< strong>Boc protection allows for controlled synthesis of these derivatives without interference from other functional groups, ensuring higher yields and purity.

The< strong>methyl ester functionality also opens up possibilities for exploring its role in peptidomimetics—molecules designed to mimic peptide sequences but with improved stability and bioavailability. Peptidomimetics have shown promise in treating various diseases by targeting specific biological pathways without eliciting off-target effects associated with traditional peptides. By leveraging N-Boc-5-hydroxytryptophan Methyl Ester, researchers can design peptidomimetics that interact selectively with serotonin receptors or other relevant targets.

Another emerging application of this compound is in the field of pain management. Serotonin receptors are implicated in modulating pain perception, particularly in neuropathic and chronic pain conditions. By synthesizing analogs of N-Boc-5-hydroxytryptophan Methyl Ester, scientists aim to develop novel analgesics that target these receptors more effectively than existing medications. The ability to modify both the protecting group and the ester moiety provides a versatile platform for creating structurally diverse compounds with tailored pharmacological profiles.

The synthesis of< strong>N-Boc-5-hydroxytryptophan Methyl Ester involves several well-established chemical transformations, including Boc protection of tryptophan and subsequent esterification at the 5-hydroxy position. These steps require precise control over reaction conditions to ensure high yield and purity. Advances in synthetic methodologies have enabled more efficient production processes, making this compound more accessible for research purposes.

In conclusion, N-Boc-5-hydroxytryptophan Methyl Ester (CAS No. 203736-17-8) stands out as a multifaceted compound with significant implications in chemical biology and medicine. Its unique structural features make it a valuable tool for synthesizing novel therapeutics targeting serotoninergic pathways. As research continues to uncover new applications for this compound, it is poised to play an increasingly important role in drug discovery and development.

• 114903-30-9(Boc-5-methoxy-L-tryptophan)
• 142847-21-0(BOC-5-METHYL-DL-TRYPTOPHAN)
• 13139-14-5(Nα-Boc-L-tryptophan)
• 5241-64-5(Na-Boc-D-tryptophan)
• 112525-72-1(2-{(tert-butoxy)carbonylamino}-3-(1H-indol-3-yl)propanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)